SCHEMBL7966967

SCHEMBL7966967

OC(CCN1CCC(c2cnc3ccccc3n2)CC1)Oc1cccc2[nH]ccc12

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 20/20 0.45
SLC6A4 P31645 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966021 0.86 HTR1A (0.47) HTR1ASLC6A4
SCHEMBL7966964 0.83 HTR1A (0.65) HTR1ASLC6A4
SCHEMBL7962234 0.82 HTR1A (0.36) HTR1ASLC6A4
SCHEMBL7966960 0.81 HTR1A (0.46) HTR1ASLC6A4
SCHEMBL7964964 0.81 HTR1A (0.47) HTR1ASLC6A4
SCHEMBL7965932 0.79 HTR1A (0.42) HTR1ASLC6A4
SCHEMBL7953373 0.77 HTR1A (0.40) HTR1ASLC6A4
SCHEMBL7965744 0.71 HTR1A (0.36) HTR1ASLC6A4
SCHEMBL7965634 0.70 HTR1A (0.47) HTR1ASLC6A4
SCHEMBL7962233 0.70 HTR1A (0.47) HTR1ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed